These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9797674)

  • 1. Mast cells in pathological and surgical scars.
    Beer TW; Baldwin H; West L; Gallagher PJ; Wright DH
    Br J Ophthalmol; 1998 Jun; 82(6):691-4. PubMed ID: 9797674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in pathological and surgical scars.
    Beer TW; Baldwin HC; Goddard JR; Gallagher PJ; Wright DH
    Hum Pathol; 1998 Nov; 29(11):1273-8. PubMed ID: 9824106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells and angiogenesis in wound healing.
    Gaber MA; Seliet IA; Ehsan NA; Megahed MA
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):32-40. PubMed ID: 24902369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic and keloid scars fail to progress from the CD34
    Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the basement membrane zone differs between keloids, hypertrophic scars and normal skin: a possible background to an impaired function.
    Hellström M; Hellström S; Engström-Laurent A; Bertheim U
    J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1564-72. PubMed ID: 25037500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of apoptosis by in situ labeling and study on the expression of PCNA in hypertrophic scars and keloids].
    Zhao BC; Qian L
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):73-6. PubMed ID: 12212258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars.
    Kischer CW; Bunce H; Shetlah MR
    J Invest Dermatol; 1978 Jun; 70(6):355-7. PubMed ID: 649983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and immunochemical differences between keloid and hypertrophic scar.
    Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G
    Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Replication of pathological scar in nude mice].
    Jin PS; Cen Y; Liu XX; Chen JJ; Xu XW; Liu Y; Li JJ; Wang Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):126-9. PubMed ID: 17649888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study.
    Saray Y; Güleç AT
    Int J Dermatol; 2005 Sep; 44(9):777-84. PubMed ID: 16135153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between angiogenesis and expression of HO-1 of scar].
    Zhu J; Luo CQ; He QY; Peng H; Zhou JD; Li P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):335-9. PubMed ID: 16045028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scar prophylaxis and treatment].
    Hammer-Hansen N; Damsgaard TE; Rødgaard JC
    Ugeskr Laeger; 2015 Oct; 177(42):V05150384. PubMed ID: 26471172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dermatology life quality index as a means to assess life quality in patients with different scar types.
    Reinholz M; Poetschke J; Schwaiger H; Epple A; Ruzicka T; Gauglitz GG
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2112-9. PubMed ID: 25866177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.